Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
47,000
Employees47,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
47,000
Employees47,000

LLY Key Statistics

Market cap
734.97B
Market cap734.97B
Price-Earnings ratio
64.24
Price-Earnings ratio64.24
Dividend yield
0.72%
Dividend yield0.72%
Average volume
3.41M
Average volume3.41M
High today
$802.50
High today$802.50
Low today
$770.00
Low today$770.00
Open price
$795.17
Open price$795.17
Volume
4.11M
Volume4.11M
52 Week high
$972.53
52 Week high$972.53
52 Week low
$677.09
52 Week low$677.09

LLY News

Simply Wall St 6d
Eli Lilly Advances Orforglipron GLP-1 Therapy To Phase 3 With Positive Results

recently announced positive Phase 3 trial results for orforglipron, the first oral small molecule GLP-1 receptor agonist showing superior A1C reduction in type...

Eli Lilly Advances Orforglipron GLP-1 Therapy To Phase 3 With Positive Results

Analyst ratings

83%

of 30 ratings
Buy
83.3%
Hold
10%
Sell
6.7%

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.